Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2-positive Recurrent / Metastatic Breast Cancer
Interventions: DRUG: pyrotinib tablet|DRUG: Montmorillonite Power|DRUG: Loperamide
Sponsor: Jiangsu HengRui Medicine Co., Ltd.